newsroompost
  • youtube
  • facebook
  • twitter
  1. Home

  2. Tag: bharat biotech

Approval to Covaxin for children aged between 2-18 years awaited after evaluation of data

Approval to Covaxin for children aged between 2-18 years awaited after evaluation of data

 Newsroom Staff
Covaxin shows 77.8% overall efficacy against COVID-19, claims Bharat Biotech in Phase 3 data

Covaxin shows 77.8% overall efficacy against COVID-19, claims Bharat Biotech in Phase 3 data

 Newsroom Staff
Bharat Biotech’s Covaxin shows 77.8% efficacy in Phase III trials, say reports

Bharat Biotech’s Covaxin shows 77.8% efficacy in Phase III trials, say reports

 Newsroom Staff
Bharat Biotech shares full data of all research studies of Covaxin

Bharat Biotech shares full data of all research studies of Covaxin

 ANI
Centre places orders for 44 crore doses of Covishield & Covaxin

Centre places orders for 44 crore doses of Covishield & Covaxin

 Newsroom Staff
Politics over Covaxin: Sisodia claims Bharat Biotech ‘denied’ vaccine to Delhi, co-founder says dispatched it on May 10

Politics over Covaxin: Sisodia claims Bharat Biotech ‘denied’ vaccine to Delhi, co-founder says dispatched it on May 10

 Newsroom Staff
Govt asks SII, Bharat Biotech to lower price of COVID vaccines: Official sources

Govt asks SII, Bharat Biotech to lower price of COVID vaccines: Official sources

 Newsroom Staff
COVAXIN neutralizes multiple variants of SARS-COV-2, double mutant strain: ICMR

COVAXIN neutralizes multiple variants of SARS-COV-2, double mutant strain: ICMR

 Newsroom Staff
GOOD NEWS: Ramping up Covaxin production, 10 crore vaccine doses/month to be churned out by September

GOOD NEWS: Ramping up Covaxin production, 10 crore vaccine doses/month to be churned out by September

 Newsroom Staff
India records 2,17,353 new Covid-19 cases and 1,185 deaths in 24 hrs, highest single-day spike

India records 2,17,353 new Covid-19 cases and 1,185 deaths in 24 hrs, highest single-day spike

 Newsroom Staff

What's New

Don't Miss

newsroompost

About Us

This site is run and owned by Headlong NewsroomPost India Private Limited.

Quick Link

 

Important Link

© 2024, All Rights Reserved by Headlong Newsroom Post India Private Limited